Cue Biopharma stock price
큐 바이오파머NASDAQ:CUE · Nasdaq · Healthcare$25.57+1.27%
2026-10-02 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Cue Biopharma last closed at $25.57 (+1.27%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -1.0×. Its overall grade ranks 669 of 739 stocks in Healthcare.
About this company
Cue Biopharma last closed at $25.57 (+1.27%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall F · 669/739
Valuation grade D
Related stocks
- AstraZenecaCustomer
Cue Biopharma의 면역치료 플랫폼 적용 가능성이 큰 글로벌 제약사
- Bristol Myers SquibbCustomer
면역항암제 분야에서 협업·기술도입 잠재 고객으로 중요한 대형 제약사
- MerckCustomer
항암·면역질환 파이프라인을 보유한 대형 제약사로 협력 가능성이 큼
About Cue Biopharma
- What technical signals does Cue Biopharma (CUE) have?
- Cue Biopharma current technical signals: no active technical signal.
- Is Cue Biopharma a cup-and-handle pattern?
- No. Cue Biopharma has no valid Cup signal right now.
- What published figures are available for Cue Biopharma?
- Market cap: $67.09M. Trailing 12 months PER: -1.0×. Latest quarter PBR: 70.19×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about Cue Biopharma, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy